Of the various immune markers profiled, only A2aR was consistently upregulated in the TIL and glioma-infiltrating myeloid-derived cell (GIM) population relative to PBMCs, including in the PBMCs from healthy donors. This evidence concerns the gene ADORA2A and central nervous system cancer.